RODRIGUEZ RAUL R 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 6, 2025
Insider Transaction Report
Form 4
RODRIGUEZ RAUL R
DirectorCEO, President
Transactions
- Sale
Common Stock
2025-02-05$21.93/sh−4,400$96,474→ 239,454 total - Sale
Common Stock
2025-02-04$20.92/sh−4,952$103,601→ 243,854 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.